This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wells, P. Articles by Price, P. Search for Related Content PubMed PubMed Citation Articles by Wells, P. Articles by Price, P.

Assessment of Inter- and Intrapatient Variability in C¹⁵O₂ Positron Emission Tomography Measurements of Blood Flow in Patients with Intra-abdominal Cancers

Department of Cancer Medicine, MRC Cyclotron Unit, Imperial College London, Hammersmith Hospital, Hammersmith, London, United Kingdom

ABSTRACT

Purpose: The aim of the study was to evaluate the inter- and intrapatient variability of positron emission tomography (PET) measurements of perfusion in advanced solid cancers.

Experimental Design: Thirty-seven patients with predominantly intra-abdominal tumors underwent PET imaging using inhaled C¹⁵O₂. Repeat data were obtained by scanning five patients twice, 1 week apart, with no intervening therapy. Regional flow and the volume of distribution (V_d) were measured from dynamic images by use of a one-compartment model. Inter- and intrapatient variability were measured as the coefficient of variability (CV). Data were also obtained for regions of interest in normal liver, spleen, and kidney.

Results: The mean (±SD) regional flow in the tumors was 0.46 ± 0.19 ml_blood/min/ml_tissue, and the mean V_d was 0.74 ± 0.15 ml_blood/ml_tissue. Variability in tumor flow was greater between (n = 37; CV = 41%) than within (n = 5; CV = 11%) patients. Variability in tumor V_d was greater between (CV = 21%) than within (CV = 6%) patients. There was a good correlation between the repeat tumor data for both regional flow ( = 0.82; P = 0.023) and V_d ( = 0.89; P = 0.007). Normal tissue variability was also greater between than within patients. In all cases, no statistically significant differences were seen between repeat measurements in the same patient.

Conclusions: Dynamic C¹⁵O₂ PET measurements of regional flow are reproducible in patients with predominantly intra-abdominal malignancies and may be useful for the pharmacodynamic evaluation of novel antivascular and antiangiogenic cancer therapeutic agents.

This article has been cited by other articles:

				J. H. Lee, E. L. Rosen, and D. A. Mankoff The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 2--Response to Therapy, Other Indications, and Future Directions J. Nucl. Med., May 1, 2009; 50(5): 738 - 748. [Abstract] [Full Text] [PDF]

				A. J. de Langen, M. Lubberink, R. Boellaard, M. D. Spreeuwenberg, E. F. Smit, O. S. Hoekstra, and A. A. Lammertsma Reproducibility of Tumor Perfusion Measurements Using 15O-Labeled Water and PET J. Nucl. Med., November 1, 2008; 49(11): 1763 - 1768. [Abstract] [Full Text] [PDF]

				M. A. Lodge, H. A. Jacene, R. Pili, and R. L. Wahl Reproducibility of Tumor Blood Flow Quantification with 15O-Water PET J. Nucl. Med., October 1, 2008; 49(10): 1620 - 1627. [Abstract] [Full Text] [PDF]

				A. J. de Langen, V. E. M. van den Boogaart, J. T. Marcus, and M. Lubberink Use of H215O-PET and DCE-MRI to Measure Tumor Blood Flow Oncologist, June 1, 2008; 13(6): 631 - 644. [Abstract] [Full Text] [PDF]

				K. D. Miller, M. Miller, S. Mehrotra, B. Agarwal, B. H. Mock, Q.-H. Zheng, S. Badve, G. D. Hutchins, and G. W. Sledge Jr. A Physiologic Imaging Pilot Study of Breast Cancer Treated with AZD2171 Clin. Cancer Res., January 1, 2006; 12(1): 281 - 288. [Abstract] [Full Text] [PDF]